Thomas Heineman
Directeur Technique/Scientifique/R&D chez ONCOLYTICS BIOTECH INC.
Fortune : 557 496 $ au 30/04/2024
Profil
Thomas C Heineman is currently the Chief Medical Officer at Oncolytics Biotech, Inc. He previously worked as the Senior Director-Clinical Research & Development at GSK Plc from 2006 to 2016.
He also held the position of Associate Professor at Saint Louis University School of Medicine.
From 2018 to 2020, he served as the Vice President & Head-Clinical Development at Halozyme Therapeutics, Inc. Additionally, he was the SVP & Head-Clinical Development at Denovo Biopharma LLC in 2020.
From 2016 to 2020, he worked as the Vice President & Head-Clinical Development at Genocea Biosciences, Inc. Dr. Heineman holds graduate and doctorate degrees from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0,68% | 07/03/2024 | 516 200 ( 0,68% ) | 557 496 $ | 30/04/2024 |
Postes actifs de Thomas Heineman
| Sociétés | Poste | Début |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Directeur Technique/Scientifique/R&D | 01/08/2020 |
Anciens postes connus de Thomas Heineman
| Sociétés | Poste | Fin |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/07/2020 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2020 |
| HALOZYME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/08/2016 |
| Saint Louis University School of Medicine | Corporate Officer/Principal | - |
Formation de Thomas Heineman
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Health Technology |